Advertisement
Palbociclib can help slow the progression of advanced breast cancer

Palbociclib Efficacious in Metastatic Breast Cancer

0
Palbociclib-letrozole combination slows disease progression

American Heart Association, Nov. 12-16

0
The American Heart Association's Scientific Sessions 2016 The annual meeting of the American Heart Association was held from Nov. 12 to 16 in...
Intrarosa (prasterone) has been approved by the U.S. Food and Drug Administration to treat women who have moderate-to-severe pain during sexual intercourse caused by postmenopausal vulvar and vaginal atrophy.

FDA Approves Intrarosa for Postmenopausal Pain During Sex

0
Drug contained in a once-daily vaginal insert
For patients with nonspecific chronic widespread musculoskeletal pain and vitamin D deficiency

Vitamin D Replacement Improves Chronic Widespread Pain

0
Improvements in patients with chronic widespread musculoskeletal pain and vitamin D deficiency
Cash prices of generic medicines to treat heart failure vary so widely that some patients may not be able to afford to fill all of their prescriptions

AHA: Wide Variation in Prices of Generic Heart Failure Meds

0
Patients can spend from $12 to $400 a month to fill prescriptions
Proton pump inhibitors at higher doses are associated with an increased risk of ischemic stroke

AHA: Proton Pump Inhibitors Tied to Ischemic Stroke Risk

0
Researchers concerned about high doses of meds like esomeprazole and omeprazole
Nearly one-third of Americans newly diagnosed with atrial fibrillation don't realize the condition puts them at increased risk for stroke

AHA: Knowledge of Stroke Risk Lacking Among A-Fib Patients

0
Study finds gaps in what patients know about atrial fibrillation
Half of patients hospitalized with atrial fibrillation aren't receiving oral anticoagulants

AHA: Many A-Fib Patients Not Receiving Oral Anticoagulants

0
Only 46 percent of patients with indications received OACs at discharge from hospital
Medication adherence is increased with receipt of care in a patient-centered medical home

Medication Adherence Up in Patient-Centered Medical Homes

0
Among matched control and medical home practices, adherence up in medical homes
For kidney transplant recipients with hepatitis C virus genotype 1 or 4 infection

Ledipasvir-Sofosbuvir Safe for Kidney Recipients With HCV

0
SVR12 for all kidney transplant recipients with HCV genotype 1, 4 after 12 or 24 weeks of treatment